DJIA 15,973.84 313.66 2.00%
NASDAQ 4,337.51 70.68 1.66%
S&P 500 1,864.78 35.70 1.95%
market minute promo

Merck & Co., Inc. (NYSE: MRK)

49.03 0.18 (0.37%)

REAL-TIME: Last trade at


company name or ticker

Recent Quotes

MRK $49.03 0.37%
Company Photos
(Click to zoom)
1D 1W 3M 6M 1Y 2Y 3Y
Today's Open $48.98
Previous Close $48.85
Daily Range $48.28 - $49.11
52-Week Range $45.69 - $61.70
Market Cap $137.0B
P/E Ratio 13.61
Dividend (Yield) $1.84 (3.8%)
Ex-Dividend Date
Dividend Pay Date
12/11/15
01/08/16
Volume 13,497,565
Average Daily Volume 13,276,884
Current FY EPS $3.57

Sector

Healthcare

Industry

Drug Makers

Merck & Co., Inc. (MRK) Description

A global research-driven pharmaceutical company that discovers, develops, manufactures and markets a range of innovative products to improve human and animal health. Website: http://www.merck.com/

News & Commentary Rss Feed

5 Key Takeaways from Organovo Holdings Inc.'s Investor Conference

Here's what you need to know about the 3D bioprinting pioneer now.

S&P 500 Weekly Update: Should Investors Be Concerned? Yes. Panic? No.

Incyte (INCY) Beats on Q4 Earnings and Revenue Estimates

Ligand (LGND) Beats on Q4 Earnings, Raises 2016 Outlook

Following Alpha: Franchise Partners - Q4 2015 Review

Notable ETF Inflow Detected - IVE, BAC, MRK, UTX

Dow Movers: DIS, V

Short Sellers Increase Bets in Major Pharma

ALK Announces Merck Submits BLA to FDA for Investigational House Dust Mite SLIT-tablet

3 Biotech Stocks to Buy in a Market Crash

Gilead Sciences, Celgene Corp, and Regeneron Pharmaceuticals are best-in-class in biotech.

See More MRK News...

MRK's Top Competitors

MRK $49.03 (0.37%)
Current stock: MRK
JNJ $101.82 (0.12%)
Current stock: JNJ
NVS $72.70 (0.69%)
Current stock: NVS
RHHBY $31.27 (0.42%)
Current stock: RHHBY